Alcohol addiction is associated with decreased limbic mGluR5 availability: a 18F-FPEB PET study in human.

被引:0
|
作者
Leurquin-Sterk, Gil [4 ]
Crunelle, Cleo [5 ]
Ceccarini, Jenny [4 ]
de Laat, Bart [2 ]
Peuskens, Hendrik [3 ]
Bormans, Guy [1 ]
Van Laere, Koen [4 ]
机构
[1] Univ Leuven, KU Leuven, Lab Radiopharm, Leuven, Belgium
[2] Univ Leuven, KU Leuven, Mol Small Anim Imaging Ctr, MoSAIC, Leuven, Belgium
[3] Univ Leuven, KU Leuven, UPC KU Leuven, Univ Psychiat Ctr, Leuven, Belgium
[4] Univ Hosp Gasthuisberg, Nucl Med, Leuven, Belgium
[5] Univ Antwerp, Toxicol Ctr, Antwerp, Belgium
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
15
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Quantitation of glutamate mGluR5 receptor with 18F-FPEB PET in humans
    Barret, Olivier
    Tamagnan, Gilles
    Batis, Jeff
    Jennings, Danna
    Zubal, George
    Russell, David
    Marek, Kennth
    Seibyl, John
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [2] Quantitation of glutamate mGluR5 receptor with 18F-FPEB PET in humans
    Barret, Olivier
    Tamagnan, Gilles
    Batis, Jeff
    Jennings, Danna
    Zubal, Georges
    Russel, David
    Marek, Ken
    Seiby, John
    NEUROIMAGE, 2010, 52 : S202 - S202
  • [3] 18F-FPEB PET Imaging Targeting the mGluR5 Receptor in Neurodegenerative Disorders
    Jennings, D.
    Seibyl, J.
    Barret, O.
    Tamagnan, G.
    Batis, J.
    Alagille, D.
    Baldwin, R.
    Zubal, G.
    Russell, D.
    Marek, K.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 30 - 30
  • [4] 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease
    Kang, Yeona
    Henchcliffe, Claire
    Verma, Ajay
    Vallabhajosula, Shankar
    He, Bin
    Kothari, Paresh J.
    Pryor, Kane O.
    Mozley, P. David
    JOURNAL OF NEUROIMAGING, 2019, 29 (01) : 97 - 103
  • [5] mGluR5 Availability in Chronic Pain: An in Vivo Study With [18F]FPEB PET Study
    Davis, Margaret
    DeBonee, Sarah
    Cool, Ryan
    Gereau, Robert
    Esterlis, Irina
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S101 - S101
  • [6] Evaluation of mGluR5 in early Parkinson's disease using 18F-FPEB PET imaging
    Jennings, D.
    Russell, D.
    Tamagnan, G.
    Barrett, O.
    Seibyl, J.
    Marek, K.
    MOVEMENT DISORDERS, 2010, 25 (07) : S383 - S384
  • [7] Evaluation of mGluR5 in Early Parkinson and Huntington Disease Using 18F-FPEB PET Imaging
    Jennings, Donna
    Marek, Kenneth
    Russell, David
    Batis, Jeff
    Koren, Andre
    Barret, Olivier
    Tamagnan, Gilles
    Seibyl, John
    NEUROLOGY, 2010, 74 (09) : A413 - A414
  • [8] In Vivo Examination of mGluR5 Availability in Chronic Pain: A [18F]FPEB PET Study
    Davis, Margaret
    Debonee, Sarah
    Cool, Ryan
    Esterlis, Irina
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 298 - 299
  • [9] Prefrontal Cortical mGluR5 Availability in PTSD: Preliminary Findings From a [18F] FPEB PET Study
    Holmes, Sophie
    Girgenti, Matthew
    Pietrzak, Robert
    Nicole, DellaGioia
    Nabeel, Nabulsi
    David, Matuskey
    Steven, Southwick
    Richard, Carson
    John, Krystal
    Irina, Esterlis
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S123 - S124
  • [10] Kinetic modeling and long-term test-retest of 18F-FPEB mGluR5 PET in healthy volunteers
    Leurquin-Sterk, Gil
    Postnov, Andrey
    Celen, Sofie
    de laat, Bart
    Bormans, Guy
    Van Laere, Koenraad
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)